RAPID DISPATCH
24/H dispatch
5 in stock
"XELA REDERM 1.8% 2ML" added to wishlist
Please login to continue
100% Secure transaction
XELA REDERM 1.8% an injectable implant based on non-crosslinked hyaluronic acid (18 mg/ml) and succinic acid, designed for the treatment of skin ageing and the overall improvement of skin quality. Thanks to redermalisation technology, the product works by restoring deep hydration, improving skin elasticity, tone and radiance.
The presence of succinic acid supports cell metabolism and helps reduce oxidative stress, resulting in firmer, more even and vital skin. XELA REDERM 1.8% is indicated for the treatment of fine and medium wrinkles, loss of elasticity and signs of photo-ageing, without creating artificial volume.
USE MEDICAL STRICT. Medical device. Use reserved for dermatologists and aesthetic doctors because they require a medical procedure.
.
Description
XELA REDERM 1.8% 2ML is a solution:
- With an isotonic and physiological formula, well tolerated by the tissues and also suitable for stressed or photo-damaged skin.
- It improves the skin's microcirculation and cell metabolism, promoting a more even and vital skin.
- With redermalising action, ideal for improving hydration, elasticity and skin quality.
- With indirect biostimulant effect by supporting cell metabolism and reducing oxidative stress.
Details
- HYALUAL
- NAME: XELA REDERM 1.8% 2ML
- COMPOSITION: High molecular weight hyaluronic acid 1.8 %, Succinic acid 1.6 %.
- PRESENTATION: 1 x 2 ml.
- NEEDLES: 2 x 30G×13mm.
- INDICATIONS: Restoration of the skin's water balance. Reduction of pigmentation, skin lightening. Alignment of the skin's micro-relief.
- INJECTION DEPTH:Superficial dermis - medium.
- DURATION: 6 to 9 months.
- USE: Strict medical use.
Packaging
- Syringe: 1 x 2 ml.
- Needles: 2 x 30G×13mm.
Treatment zones
Facial contours and mimic wrinkles.
Composition
High molecular weight hyaluronic acid 1.8 %, succinic acid 1.6 %.
Precautions for use
- The product must only be used by qualified medical personnel experienced in aesthetic medicine.
- Carry out a thorough patient history before treatment, assessing allergies, current therapies and clinical conditions.
- Use strict aseptic techniques and sterile disposable material.
- Avoid administration in areas recently treated with other injectable devices, unless medically assessed.
- Do not mix the product with other substances or drugs not expressly indicated.
- Inform the patient of the possible occurrence of transient local reactions (redness, oedema, slight pain or a feeling of tension).
- After treatment, avoid exposure to intense heat, UV radiation, vigorous massage or intense physical activity for the period indicated by the doctor.
Contraindications
XELA REDERM 1.8% 2ML is contraindicated in the following cases:
- Known hypersensitivity or allergy to hyaluronic acid, succinic acid or any of the components of the product.
- Presence of active skin infections, inflammation, dermatitis or lesions in the area to be treated.
- Active autoimmune diseases or uncontrolled conditions of immunodepression.
- Pregnancy and lactation.
- Previous significant adverse reactions to hyaluronic acid-based injectable treatments.
- Clotting disorders or unstabilised anticoagulant therapy.
- Patients below the age stipulated in the device indications.
Directions
The preparation is used for complex skin rejuvenation: it restores a healthy complexion, lightens pigmentation spots, improves skin tone and texture, increases elasticity and reduces the appearance of wrinkles.
FAQ
.What is XELA REDERM 1.8% and how does it differ from a traditional filler?
XELA REDERM 1.8% is an injectable implant based on non-crosslinked hyaluronic acid and succinic acid, designed to improve the quality of the skin through a redermalising action. Unlike volumising fillers, it does not create artificial volume but acts on deep hydration, elasticity and skin vitality.
What benefits does the succinic acid in the formulation offer?
Succinic acid supports cell metabolism and helps reduce oxidative stress. This action promotes a firmer, more even and radiant skin, improving skin tone and counteracting signs of ageing and photo-ageing.
For which imperfections is XELA REDERM 1.8% indicated?
The treatment is indicated for fine and medium wrinkles, loss of elasticity, dull complexion, skin dehydration and dyschromia related to photo-ageing. It is particularly suitable for those who want an overall rejuvenation of the skin without volumising effects.
In which areas of the face can the product be used?
XELA REDERM 1.8% is indicated for facial contours and mimic wrinkles, where it helps improve skin micro-relief, hydration and overall skin quality.
How long do the effects of the treatment last?
The results of the treatment have an approximate duration of between 6 and 9 months. The duration may vary depending on the skin condition, the patient's lifestyle and the treatment protocol established by the doctor.
Italian 
English 